Precision BioSciences Reshapes Finance and Operations

Company Precision BioSciences Event Type Leadership Transition (Internal Promotions) Modality In vivo gene editing (ARCUS nuclease platform) Platform ARCUS gene-editing platform Indication Chronic hepatitis B (PBGENE-HBV) and Duchenne muscular dystrophy (PBGENE-DMD) Summary Precision BioSciences promoted CFO Alex Kelly into a newly created chief operating officer…